Maintenance dose
A maintenance dose is the steady dose of an antidepressant you keep taking after the initial course of treatment has worked, to keep its effect stable and lower the chance that depression comes back. It is usually the dose that got you well. Guidelines suggest staying on it for at least six months after you feel better, and longer if depression has come back before, and then reviewing it with your prescriber.
Also called: Maintenance treatment, Continuation dose, Staying on an antidepressant.
Written by Alena Kozlova, PhD, from published studies and prescribing information.
Definition medically reviewed by Dr. Jason Tan, Consultant Psychiatrist, on November 11, 2026, this definition only. Next review: November 11, 2027.
Why keep taking an antidepressant after you feel better?
Because feeling better does not mean the risk of relapse has gone. US prescribing information is where that shows up first. The Zoloft label reports a 44-week study in people who had responded to 8 weeks of sertraline and were then kept on it or moved to a placebo: 8% of those kept on sertraline relapsed, against 39% of those on the placebo. The trials test staying on the medication rather than any exact number of milligrams, which is why the dose itself stays a question for your prescriber.
A 2021 trial in the New England Journal of Medicine looked at the same choice in general practice. It followed 478 adults at UK practices who were taking citalopram, fluoxetine, sertraline or mirtazapine and felt well enough to consider stopping, randomly assigned to keep their antidepressant or to come off it: 56% of those who came off relapsed within the 52 weeks of the trial, against 39% of those who stayed on it. Everyone in that trial had either had at least two episodes of depression or taken an antidepressant for two years or more, so it says little about a first short course, and it says nothing directly about the medications it did not include.
How long do people stay on a maintenance dose?
There is no single length that fits everyone. The US labels describe months rather than weeks: the Zoloft study ran 44 weeks past the first 8. UK guidance from the NHS puts a floor under it and says you will usually take an antidepressant for at least 6 months after you feel better. Past that, the length depends on how many episodes you have had and how stopping went last time.
Agree a date with your prescriber to come back to the question, so it is on the calendar rather than left open.
What happens when a maintenance dose is lowered?
Lowering it can bring on withdrawal symptoms. The US labels for Lexapro and Zoloft both say to reduce the dose gradually rather than stop abruptly whenever possible, and the Lexapro label adds that if intolerable symptoms follow a decrease, resuming the previously prescribed dose may be considered. A 2019 analysis in The Lancet Psychiatry argues for steps that get smaller in milligrams as the dose falls, which is the thinking behind hyperbolic tapering, and that term has its own page.
Symptoms after a cut can also look like the depression returning. Horowitz and Taylor point out that withdrawal is often mistaken for the illness coming back, and telling the two apart is what the next decision turns on, so it is work for you and your prescriber together. The pace, the size of each step and what to do if a step goes badly are easier to set before you start than halfway down.
What to do
If you wonder whether you still need your dose, ask your prescriber for a review rather than lowering it yourself. Bring a note of how long you have felt well, how many episodes you have had, and any side effects that bother you. If your mood drops sharply, contact your prescriber without waiting for the planned review. If you have thoughts of harming yourself, call or text 988 in the US, or your local emergency number.
See what a gradual reduction could look like
How withClaro helps
- A record of your mood and side effects on your current dose
- A PDF report to bring to your prescriber review
Get the withClaro app on the App Store
Related terms
Sources
- Lewis G, Marston L, Duffy L, Freemantle N, Gilbody S, Hunter R. Maintenance or Discontinuation of Antidepressants in Primary Care. New England Journal of Medicine, 2021.
- U.S. Food and Drug Administration. Zoloft (sertraline) tablets and oral solution: prescribing information. FDA / DailyMed, 2025.
- U.S. Food and Drug Administration. Lexapro (escitalopram) tablets and oral solution: prescribing information. FDA / DailyMed, 2026.
- Horowitz MA, Taylor D. Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet Psychiatry, 2019.
- National Health Service (NHS). Antidepressants: Overview. NHS, 2026.
All glossary terms